120 related articles for article (PubMed ID: 30789201)
1. MIG in Cutaneous Systemic Lupus Erythematosus.
Ruffilli I
Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
[TBL] [Abstract][Full Text] [Related]
2. Interferon-γ-inducible chemokines in systemic lupus erythematosus.
Elia G
Clin Ter; 2015; 166(1):e41-6. PubMed ID: 25756266
[TBL] [Abstract][Full Text] [Related]
3. Dermatomyositis and MIG.
Ragusa F
Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis and the Th1 chemokine MIG.
Paparo SR
Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
[TBL] [Abstract][Full Text] [Related]
5. Sarcoidosis and the Th1 chemokine MIG.
Ragusa F
Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
[TBL] [Abstract][Full Text] [Related]
6. MIG Th1 chemokine in Vitiligo.
Elia G
Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
[TBL] [Abstract][Full Text] [Related]
7. Type 1 diabetes and MIG.
Gonnella D
Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
[TBL] [Abstract][Full Text] [Related]
8. Sarcoidosis and the alpha chemokine MIG.
Giusti C
Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
[TBL] [Abstract][Full Text] [Related]
9. The MIG Chemokine in Inflammatory Myopathies.
Paparo SR
Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
[TBL] [Abstract][Full Text] [Related]
10. CXCL9 chemokine in ulcerative colitis.
Elia G; Guglielmi G
Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
[TBL] [Abstract][Full Text] [Related]
11. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
[TBL] [Abstract][Full Text] [Related]
12. MIG in Crohn's disease.
Caruso C
Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
[TBL] [Abstract][Full Text] [Related]
13. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
14. Sjögren syndrome and MIG.
Ruffilli I
Clin Ter; 2019; 170(6):e478-e482. PubMed ID: 31696913
[TBL] [Abstract][Full Text] [Related]
15. The Th1 chemokine MIG in Graves' ophthalmopathy.
Gonnella D
Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
[TBL] [Abstract][Full Text] [Related]
16. Mig chemokine in primary biliary cirrhosis.
Mazzi V
Clin Ter; 2019; 170(3):e211-e215. PubMed ID: 31173052
[TBL] [Abstract][Full Text] [Related]
17. Th1 chemokines in ulcerative colitis.
Ragusa F
Clin Ter; 2015; 166(2):e126-31. PubMed ID: 25945446
[TBL] [Abstract][Full Text] [Related]
18. CXCR3 <-> ligand-mediated skin inflammation in cutaneous lichenoid graft-versus-host disease.
Wenzel J; Lucas S; Zahn S; Mikus S; Metze D; Ständer S; von Stebut E; Hillen U; Bieber T; Tüting T
J Am Acad Dermatol; 2008 Mar; 58(3):437-42. PubMed ID: 18280341
[TBL] [Abstract][Full Text] [Related]
19. Heparin displaces interferon-gamma-inducible chemokines (IP-10, I-TAC, and Mig) sequestered in the vasculature and inhibits the transendothelial migration and arterial recruitment of T cells.
Ranjbaran H; Wang Y; Manes TD; Yakimov AO; Akhtar S; Kluger MS; Pober JS; Tellides G
Circulation; 2006 Sep; 114(12):1293-300. PubMed ID: 16940188
[TBL] [Abstract][Full Text] [Related]
20. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
Neo SY; Lundqvist A
Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]